2023-11-09 08:36:55 ET
- Losers: Atara Biotherapeutics ATRA -58% falls 50% after-hours on failed Phase 2 study for MS drug.
- Assertio Holdings ASRT -46% after Q3 earning release .
- Cardlytics CDLX -36% after Q3 earning release .
- Inspired Entertainment ( INSE ) -31% .
- Ebix ( EBIX ) -29% .
- NuScale Power Corporation SMR -26% after Q3 earning release .
- Topgolf Callaway Brands Corp MODG -22% after Q3 earning release .
- Amylyx Pharmaceuticals AMLX -17% . after Q3 earning release .
- Digital Turbine APPS -12% after Q2 earning release .
- BILL Holdings BILL -11% on report of $1.95B deal talks for Melio Payments.
- CCC Intelligent Solutions Holdings CCCS -9% proposes secondary offering of 50M shares , including concurrent. repurchases
- Liveperson LPSN -9% after Q3 earning release .
- Luminar Technologies LAZR -8% after Q3 earning release .
- Ginkgo Bioworks Holdings DNA -9% after Q3 earning release .
- IonQ IONQ -8% after Q3 earning release .
- scPharmaceuticals SCPH -8% after Q3 earning release .
- Veeva Systems ( VEEV ) -7% .
- Biolase ( BIOL ) -7% .
- Globavend Holdings Limited ( GVH ) -7% .
- Smith Micro Software SMSI -7% after Q3 earning release .
- Arm Holdings ARM -6% after Q2 earning release .
- AerSale Corp ASLE -6% after Q3 earning release .
For further details see:
VEEV, DNA and EBIX among pre-market losers